Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Sulfo-Cy3 NHS Ester: Sulfonated Fluorescent Dye for Prote...

    2026-01-12

    Sulfo-Cy3 NHS Ester: Sulfonated Fluorescent Dye for Protein Labeling Excellence

    Principle and Setup: The Science Behind Sulfo-Cy3 NHS Ester

    Fluorescent labeling of amino groups in proteins and peptides is a cornerstone of modern biochemical and cell biology research, enabling visualization, quantification, and mechanistic studies of complex biomolecular processes. Sulfo-Cy3 NHS Ester (SKU: A8107), supplied by APExBIO, exemplifies next-generation sulfonated fluorescent dye for protein labeling. Its unique structure features sulfonate groups that confer exceptional hydrophilicity, facilitating solubility and reactivity in aqueous environments without the need for organic co-solvents.

    The core mechanism leverages the NHS (N-hydroxysuccinimide) ester chemistry, which targets primary amines—most notably lysine residues—on proteins, peptides, and other biomolecules. The result is a covalent, stable conjugate with robust fluorescent properties (excitation: 563 nm, emission: 584 nm, extinction coefficient: 162,000 M⁻¹cm⁻¹, quantum yield: 0.1). This hydrophilic fluorescent dye is particularly advantageous for labeling low-solubility or aggregation-prone proteins without compromising their native structure or function—a critical advantage for studying delicate systems such as capillary endothelial cells or cytoskeletal proteins.

    Enhanced Experimental Workflow: Step-by-Step Protocol

    1. Preparation and Solubilization

    • Reagent Handling: Sulfo-Cy3 NHS Ester is provided as a solid, requiring protection from light and storage at -20°C. Solid dye is insoluble in water, DMSO, or ethanol, but dissolves rapidly in buffered aqueous solutions (e.g., PBS, pH 7.2–8.5) upon gentle vortexing or pipetting.
    • Protein Solution: Prepare your target protein or peptide at 1–10 mg/mL in a suitable buffer lacking primary amine contaminants (avoid Tris, glycine, or ammonium sulfate).

    2. Conjugation Reaction

    • Calculate the optimal molar ratio (usually 3–10:1 dye:protein for most applications) to balance labeling efficiency with functional integrity.
    • Add Sulfo-Cy3 NHS Ester solution to the protein under gentle stirring. Incubate at room temperature (20–25°C) for 30–60 minutes, shielded from ambient light.
    • Monitor the pH (ideally 7.5–8.5) to maximize NHS-ester reactivity and minimize hydrolysis.

    3. Purification and Quality Control

    • Remove excess dye via size-exclusion chromatography, ultrafiltration, or dialysis.
    • Quantify labeling efficiency by measuring absorbance at 280 nm (protein) and 563 nm (Cy3 dye), adjusting for dye contribution to protein absorbance. Typical labeling yields range from 2–5 sulfo-Cy3 labels per protein, with >90% recovery and minimal free dye.
    • Store conjugates at 4°C in the dark for short-term use, or aliquot and freeze for longer-term storage.

    This optimized workflow, validated in scenario-driven guides such as the Reliable Fluorescent Labeling in Cell Biology Assays, ensures reproducibility and high sensitivity even for challenging protein targets.

    Advanced Applications and Comparative Advantages

    Unmatched Hydrophilicity for Difficult Proteins

    Traditional fluorescent dyes often require organic co-solvents that can denature or aggregate sensitive proteins. In contrast, Sulfo-Cy3 NHS Ester’s sulfonated structure yields a hydrophilic fluorescent dye for low solubility proteins, supporting native folding and biological activity during and after labeling. This capability was instrumental in translational vascular research, such as the study by Zhu et al. (Science Advances, 2025), where Sulfo-Cy3 labeling enabled the tracking of CXCR4+ stemlike capillary endothelial cells during collateral circulation remodeling. The dye’s reduced fluorescence quenching—thanks to its sulfonation—ensured clear, quantitative imaging of cellular dynamics in complex tissue environments.

    Quantum Dot-Dye Conjugate Synthesis

    Sulfo-Cy3 NHS Ester is a preferred bioconjugation reagent for QD-dye conjugates synthesis, offering efficient covalent linkage to amino-functionalized quantum dots (QDs). This enables multiplexed, high-contrast detection in single-cell studies or high-content screening, as highlighted in Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Protein Labeling. The workflow is streamlined by the dye’s solubility and stability in aqueous media, reducing background and improving multiplexing fidelity.

    Fluorescent Probes for Cell Biology and Vascular Remodeling

    As a fluorescent probe for cell biology, Sulfo-Cy3 NHS Ester supports advanced imaging modalities—including confocal microscopy and flow cytometry—by delivering high signal-to-noise ratios and minimal background fluorescence. In comparative benchmarking, labeling with Sulfo-Cy3 NHS Ester consistently outperforms non-sulfonated analogs in sensitivity and reproducibility, especially in live-cell and tissue studies where native protein function must be preserved (Next-Generation Probe for Protein Labeling).

    Troubleshooting and Optimization Tips

    Common Challenges and Solutions

    • Low Labeling Efficiency: Confirm protein concentration and buffer compatibility. Avoid buffers with competing amines (e.g., Tris). Increase incubation time or dye:protein ratio if necessary.
    • Protein Aggregation or Loss of Activity: Leverage the hydrophilic properties of Sulfo-Cy3 NHS Ester to bypass organic solvents. For extremely sensitive proteins, perform conjugation at 4°C and minimize agitation.
    • High Background or Free Dye: Implement rigorous purification steps (gel filtration, ultrafiltration) and verify removal of unconjugated dye spectrophotometrically.
    • Photobleaching: Protect all solutions and conjugates from light during and after labeling. Use anti-fade mounting media for imaging applications.
    • Batch-to-Batch Variability: Source from reliable vendors such as APExBIO, and adhere to validated protocols for consistent outcomes (Optimizing Protein Labeling: Evidence-Based Scenarios).

    Quantitative Performance Insights

    Recent studies report labeling yields of 2.3–4.7 dye molecules per IgG, with negligible impact on antigen binding and cell viability. Sulfo-Cy3 NHS Ester’s high extinction coefficient (162,000 M⁻¹cm⁻¹) translates to enhanced detection limits, making it suitable for low-abundance targets in proteomics or immunoassays. Its quantum yield (0.1) delivers sufficient brightness for most imaging and quantification needs while minimizing photo-induced damage.

    Future Outlook: Sulfo-Cy3 NHS Ester in Next-Generation Research

    The evolving landscape of vascular biology and regenerative medicine increasingly demands fluorescent labeling tools that combine specificity, sensitivity, and biological compatibility. As demonstrated in the AIBP-LRP2–mediated HDL uptake study, advanced probes like Sulfo-Cy3 NHS Ester are pivotal for dissecting mechanisms of cell fate, vascular remodeling, and therapeutic revascularization. Emerging applications—including multiplexed imaging, real-time in vivo tracking, and single-molecule proteomics—are poised to benefit from the dye’s hydrophilicity, stability, and reduced quenching.

    Complementing these breakthroughs, the article Sulfo-Cy3 NHS Ester: A Strategic Catalyst for Translational Research emphasizes the reagent’s role in bridging experimental gaps and accelerating the translation of discovery into therapy. As new frontiers in vascular biology and cell engineering emerge, Sulfo-Cy3 NHS Ester, reliably supplied by APExBIO, will remain central to robust, reproducible, and high-impact biomolecular research.

    Conclusion

    Sulfo-Cy3 NHS Ester stands apart as a bioconjugation reagent for biomolecules, empowering researchers to achieve efficient, reproducible, and sensitive protein conjugation with Cy3 dye. From foundational studies of endothelial cell remodeling to the synthesis of high-performance QD-dye conjugates, its unique properties support a spectrum of advanced applications. By integrating robust protocols, troubleshooting insights, and comparative advantages, Sulfo-Cy3 NHS Ester unlocks new possibilities for fluorescent labeling in the life sciences.